211 related articles for article (PubMed ID: 34289327)
1. MRI findings in-between leiomyoma and leiomyosarcoma: a Rad-Path correlation of degenerated leiomyomas and variants.
Bura V; Pintican RM; David RE; Addley HC; Smith J; Jimenez-Linan M; Lee J; Freeman S; Georgiu C
Br J Radiol; 2021 Sep; 94(1125):20210283. PubMed ID: 34289327
[TBL] [Abstract][Full Text] [Related]
2. Explorative Investigation of Whole-Lesion Histogram MRI Metrics for Differentiating Uterine Leiomyomas and Leiomyosarcomas.
Gerges L; Popiolek D; Rosenkrantz AB
AJR Am J Roentgenol; 2018 May; 210(5):1172-1177. PubMed ID: 29547053
[TBL] [Abstract][Full Text] [Related]
3. MR imaging findings of unusual leiomyoma and malignant uterine myometrial tumors: what the radiologist should know.
Fujii S; Mukuda N; Ochiai R; Yunaga H; Murakami A; Gonda T; Kishimoto M; Yamaji D; Ishibashi M
Jpn J Radiol; 2021 Jun; 39(6):527-539. PubMed ID: 33517507
[TBL] [Abstract][Full Text] [Related]
4. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging.
Sun S; Bonaffini PA; Nougaret S; Fournier L; Dohan A; Chong J; Smith J; Addley H; Reinhold C
Diagn Interv Imaging; 2019 Oct; 100(10):619-634. PubMed ID: 31427216
[TBL] [Abstract][Full Text] [Related]
5. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment?
DeMulder D; Ascher SM
AJR Am J Roentgenol; 2018 Dec; 211(6):1405-1415. PubMed ID: 30354268
[TBL] [Abstract][Full Text] [Related]
6. European Society of Urogenital Radiology (ESUR) Guidelines: MR Imaging of Leiomyomas.
Kubik-Huch RA; Weston M; Nougaret S; Leonhardt H; Thomassin-Naggara I; Horta M; Cunha TM; Maciel C; Rockall A; Forstner R
Eur Radiol; 2018 Aug; 28(8):3125-3137. PubMed ID: 29492599
[TBL] [Abstract][Full Text] [Related]
7. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?
Rio G; Lima M; Gil R; Horta M; Cunha TM
Abdom Radiol (NY); 2019 Oct; 44(10):3388-3397. PubMed ID: 31250178
[TBL] [Abstract][Full Text] [Related]
8. Uterine sarcomas versus leiomyomas: gray-scale and Doppler sonographic findings.
Aviram R; Ochshorn Y; Markovitch O; Fishman A; Cohen I; Altaras MM; Tepper R
J Clin Ultrasound; 2005 Jan; 33(1):10-3. PubMed ID: 15690441
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology.
Russo C; Camilli S; Martire FG; Di Giovanni A; Lazzeri L; Malzoni M; Zupi E; Exacoustos C
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):269-276. PubMed ID: 35018681
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of atypical fibroids.
Bolan C; Caserta MP
Abdom Radiol (NY); 2016 Dec; 41(12):2332-2349. PubMed ID: 27826698
[TBL] [Abstract][Full Text] [Related]
11. Uterine smooth muscle tumours with hyperintense area on T
Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
[TBL] [Abstract][Full Text] [Related]
12. Smooth Muscle Tumors of the Uterus at MRI: Focus on Leiomyomas and FIGO Classification.
Tu W; Yano M; Schieda N; Krishna S; Chen L; Gottumukkala RV; Alencar R
Radiographics; 2023 Jun; 43(6):e220161. PubMed ID: 37261965
[TBL] [Abstract][Full Text] [Related]
13. Utility of magnetic resonance imaging for differentiating malignant mesenchymal tumors of the uterus from T2-weighted hyperintense leiomyomas.
Matsuura K; Inoue K; Hoshino E; Yasuda M; Hasegawa K; Okada Y; Baba Y; Kozawa E
Jpn J Radiol; 2022 Apr; 40(4):385-395. PubMed ID: 34750737
[TBL] [Abstract][Full Text] [Related]
14. Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.
Kumagai K; Yagi T; Yamazaki M; Tasaki A; Asatani M; Ishikawa H
Medicine (Baltimore); 2023 Aug; 102(31):e34452. PubMed ID: 37543807
[TBL] [Abstract][Full Text] [Related]
15. Development of Uterine Leiomyosarcoma During Follow-up After Caesarean Section in a Woman With Uterine Leiomyoma.
Watanabe K; Hayashi T; Katsumata M; Sano K; Abiko K; Konishi I
Anticancer Res; 2021 Jun; 41(6):3001-3010. PubMed ID: 34083291
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
17. Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.
Lee JH; Ryu TY; Cho CH; Kim DK
Pathol Oncol Res; 2011 Jun; 17(2):201-5. PubMed ID: 20853077
[TBL] [Abstract][Full Text] [Related]
18. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
19. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging features of uterine sarcoma and mimickers.
Barral M; Placé V; Dautry R; Bendavid S; Cornelis F; Foucher R; Guerrache Y; Soyer P
Abdom Radiol (NY); 2017 Jun; 42(6):1762-1772. PubMed ID: 28246921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]